Zobrazeno 1 - 10
of 73
pro vyhledávání: '"AL Petzer"'
Publikováno v:
Journal of cancer research and clinical oncology. 148(11)
Purpose: Incidence and mortality of colorectal cancer (CRC) declined over the last decades. However, survival depends on the primary tumor location. It is unknown if all progress in outcomes vary depending on left-sided (LCRC) versus right sided (RCC
Autor:
Michaela Binder, Emine Kaynak, Dominik Wolf, Petra Hasengruber, Irene Strassl, Olga Stiefel, Ansgar Weltermann, Dagmar Wipplinger, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Robert Milanov, Helga Wagner, Johannes Clausen, AL Petzer, David Nachbaur, Alexander Nikoloudis
Publikováno v:
Transplantation and cellular therapy. 27(8)
Although the risk for nonrelapse mortality (NRM) associated with early cytomegalovirus (CMV) reactivation (CMVR) after allogeneic hematopoietic stem cell transplantation (HSCT) is well established, debate is ongoing on whether CMVR may reduce the ris
Autor:
Eberhard Gunsilius, Günther Gastl, Kurt Grünewald, Johannes Clausen, G. Stockhammer, Hans-Christoph Duba, AL Petzer, Christoph Gabl, Christian M. Kähler, Stephan Dirnhofer
Publikováno v:
The Lancet. 355:1688-1691
Summary Background Vascular endothelial cells lost from the bloodvessel endothelium through necrosis or apoptosis must be replaced. We investigated in a leukaemia model whether bone-marrow-derived endothelial cells contribute to this maintenance angi
Autor:
U Zilian, AL Petzer, R Bilgeri, Francoise Geisen, Herbert Braunsteiner, M Haun, I Pragnell, Günther Konwalinka
Publikováno v:
Blood. 78:2583-2587
Previous studies have shown that 2-chloro-2′-deoxyadenosine (CdA) is markedly toxic to normal and malignant human lymphocytes in vitro and in vivo. Recent clinical trials have shown that CdA is a very promising drug for the treatment of lymphoid ma
Publikováno v:
Lancet (London, England). 357(9266)
Publikováno v:
Circulation Research. 88
To the Editor: Crosby et al1 noted in their report that the recruitment of bone marrow–derived endothelial progenitor cells to newly forming blood vessels might have been hitherto overlooked. Postulated already a century ago,2 there is now ample ev
Autor:
Josef Thaler, Francoise Geisen, Michael Schirmer, Wolfgang Hilbe, Falko Fend, Anton Knoblechner, Günther Konwalinka, AL Petzer
Publikováno v:
Blood cells, moleculesdiseases. 21(2)
Some patients in apparent complete remission of hairy cell leukemia (HCL) after 2-chlorodeoxyadenosine (2-CdA) treatment may have minimal residual disease (MRD). This study examines detection of minimal residual disease by immunohistological staining
Publikováno v:
The Lancet. 356:1026-1027
Sir—Eberhard Gunsilius and colleagues (May 13, p 1688) raise intriguing issues as to whether chronic myelogenous leukaemia originates in a persisting haemangioblast, or whether either malignancy de-differentiates a relatively committed haemopoietic
Publikováno v:
British Journal of Haematology. 108:661-662
Autor:
Christian J. Wiedermann, Dietmar Geissler, AL Petzer, Christoph Breier, Günther Konwalinka, Kurt Grünewald, Josef R. Patsch
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781468455731
In order to investigate cellular mechanisms involved in insulin stimulation of erythropoiesis, we have studied the response of early (BFU-e) and late (CFU-e) erythroid progenitor cells in a serum-free agar culture system. In this assay system, CFU-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93a715f4fcd97611aee6fbad94432321
https://doi.org/10.1007/978-1-4684-5571-7_30
https://doi.org/10.1007/978-1-4684-5571-7_30